CCAP Stock Crescent Capital BDC (CCAP, $15.13) Moving Average Convergence Divergence (MACD) Histogram turned positive on April 21, 2025

GET DAILY SIGNALS

Get AI intraday signals

CCAP - Crescent Capital BDC

MACD signal

View

Odds of UP Trend

Price: $15.13

Daily change: -$0.37 (-2.39%)

Daily volume: 127.1K

Capitalization: $560.7M

Industry: Investment Managers

CCAP's RSI Indicator ascending out of oversold territory

The RSI Indicator for CCAP moved out of oversold territory on April 14, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 15 similar instances when the indicator left oversold territory. In of the 15 cases the stock moved higher. This puts the odds of a move higher at .

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on April 22, 2025. You may want to consider a long position or call options on CCAP as a result. In of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CCAP just turned positive on April 21, 2025. Looking at past instances where CCAP's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CCAP advanced for three days, in of 322 cases, the price rose further within the following month. The odds of a continued upward trend are .

CCAP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The 50-day moving average for CCAP moved below the 200-day moving average on April 09, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CCAP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for CCAP entered a downward trend on April 08, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.857) is normal, around the industry mean (2.779). P/E Ratio (7.373) is within average values for comparable stocks, (27.202). Projected Growth (PEG Ratio) (0.892) is also within normal values, averaging (3.172). Dividend Yield (0.095) settles around the average of (0.071) among similar stocks. P/S Ratio (6.676) is also within normal values, averaging (11.704).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 68, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CCAP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.